Research and Markets has announced the addition of the "Global Proton Therapy Market Outlook 2021" report to their offering.

Global Proton Therapy Market Outlook 2021 provides an in-depth analysis of global proton therapy treatment market with focus on major regional market such as North America, Europe and Asia Pacific.

North America is the world's largest proton therapy market with high predominance in the US. In Europe, Germany and the UK are major markets. The proton therapy systems market has been segmented into pencil beam scanning systems, uniform scanning systems and passive scattering systems on the basis of type of system. Out of these, pencil beam scanning being most precise form of proton therapy enjoys highest popularity.

Growth of the global proton therapy industry is driven by rise in cancer incidences, especially prostate cancer. Rising prevalence of chronic diseases in ageing population globally; and minimal invasiveness associated with use of proton therapy. However, major industry restraints include stringent regulations, high installation costs and reimbursement being limited to few uncommon cancer types.

Global proton therapy industry is highly consolidated with three major players - IBA Proton Therapy Inc, Varian Medical Systems and Hitachi Limited dominating the market. These players have been profiled in the report.

Key Vendors:

- IBA Proton Therapy Inc

- Varian Medical Systems

- Hitachi Ltd

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Proton Therapy

4. Proton Therapy Market Analysis

5. Global Proton Therapy Market: Regional Analysis

6. Proton Therapy Market Dynamics

7. Competitive Landscape

8. Company Profiles

For more information about this report visit http://www.researchandmarkets.com/research/g4xwz2/global_proton